These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

516 related items for PubMed ID: 19662654

  • 1. Small molecule antagonists of Tcf4/beta-catenin complex inhibit the growth of HCC cells in vitro and in vivo.
    Wei W, Chua MS, Grepper S, So S.
    Int J Cancer; 2010 May 15; 126(10):2426-36. PubMed ID: 19662654
    [Abstract] [Full Text] [Related]

  • 2. Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells.
    Wei W, Chua MS, Grepper S, So SK.
    Mol Cancer; 2009 Sep 24; 8():76. PubMed ID: 19778454
    [Abstract] [Full Text] [Related]

  • 3. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW, Choi H, So D, Kim YI, Cho K, Chung HJ, Lee KH, Chun YS, Cho CH, Kang GH, Kim WH, Park JW.
    Gastroenterology; 2014 Aug 24; 147(2):430-442.e8. PubMed ID: 24846398
    [Abstract] [Full Text] [Related]

  • 4. Interferon-α2b and transforming growth factor-β1 treatments on HCC cell lines: Are Wnt/β-catenin pathway and Smads signaling connected in hepatocellular carcinoma?
    Ceballos MP, Parody JP, Alvarez Mde L, Ingaramo PI, Carnovale CE, Carrillo MC.
    Biochem Pharmacol; 2011 Dec 01; 82(11):1682-91. PubMed ID: 21843516
    [Abstract] [Full Text] [Related]

  • 5. 20(S)-ginsenoside Rh2 inhibits the proliferation and induces the apoptosis of KG-1a cells through the Wnt/β-catenin signaling pathway.
    Chen Y, Liu ZH, Xia J, Li XP, Li KQ, Xiong W, Li J, Chen DL.
    Oncol Rep; 2016 Jul 01; 36(1):137-46. PubMed ID: 27121661
    [Abstract] [Full Text] [Related]

  • 6. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
    Ma L, Wang X, Jia T, Wei W, Chua MS, So S.
    Oncotarget; 2015 Sep 22; 6(28):25390-401. PubMed ID: 26246473
    [Abstract] [Full Text] [Related]

  • 7. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE, Wang MX, Li RQ.
    Cancer Invest; 2009 Jul 22; 27(6):604-12. PubMed ID: 19440933
    [Abstract] [Full Text] [Related]

  • 8. Soluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicin.
    Wei W, Chua MS, Grepper S, So SK.
    Mol Cancer; 2011 Feb 11; 10():16. PubMed ID: 21314951
    [Abstract] [Full Text] [Related]

  • 9. Antitumor activity of natural compounds, curcumin and PKF118-310, as Wnt/β-catenin antagonists against human osteosarcoma cells.
    Leow PC, Tian Q, Ong ZY, Yang Z, Ee PL.
    Invest New Drugs; 2010 Dec 11; 28(6):766-82. PubMed ID: 19730790
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Preclinical evaluation of destruxin B as a novel Wnt signaling target suppressing proliferation and metastasis of colorectal cancer using non-invasive bioluminescence imaging.
    Yeh CT, Rao YK, Ye M, Wu WS, Chang TC, Wang LS, Wu CH, Wu AT, Tzeng YM.
    Toxicol Appl Pharmacol; 2012 May 15; 261(1):31-41. PubMed ID: 22465936
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inhibition of the Wnt/β-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma.
    Lin HH, Feng WC, Lu LC, Shao YY, Hsu CH, Cheng AL.
    Cancer Lett; 2016 Oct 10; 381(1):58-66. PubMed ID: 27431312
    [Abstract] [Full Text] [Related]

  • 14. SC-III3, a novel scopoletin derivative, induces cytotoxicity in hepatocellular cancer cells through oxidative DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation.
    Zhao P, Chen L, Li LH, Wei ZF, Tong B, Jia YG, Kong LY, Xia YF, Dai Y.
    BMC Cancer; 2014 Dec 19; 14():987. PubMed ID: 25527123
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.